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Urinary isoflavone excretion is used to monitor compliance and examine biological effects. The present study determined if there were
alterations in urinary isoflavone excretion following the ingestion of different soya foods and if age and gender potentially modified
profiles. Twenty premenopausal women, seventeen post-menopausal women and twenty men received a defined single oral bolus dose
(0·44 mg isoflavones/kg body weight) of soya milk, textured vegetable protein (TVP) or tempeh on three separate occasions. Baseline
and four consecutive complete 24 h pooled urines were collected during each period. Urinary genistein recovery was influenced by
gender and food matrix. For women the urinary genistein recovery was higher following soya-milk consumption compared with TVP
(P,0·05). Tempeh consumption also resulted in an increased urinary genistein recovery relative to soya milk in premenopausal
women (P,0·052). No differences in urinary genistein recoveries between soya foods were observed in the men. Although urinary daid-
zein excretion was similar across the foods studied and was not affected by age or gender, conversion to its intestinal metabolite, equol,
resulted in potential matrix and chemical composition effects; urinary equol excretion was higher (P,0·01) following tempeh ingestion
among equol producers. Together these data suggest that the fractional absorption of genistein is potentially different in men and women
and is influenced by the food matrix and chemical composition. Furthermore, the data suggest that the metabolism of daidzein may be
altered by the chemical composition of the isoflavones ingested. Further studies are required to examine the effect of higher intake
and define the relative influence of these factors in elderly population groups.
Soya: Isoflavones: Bioavailability
Although there has been interest in the potential risks and
benefits of consuming diets rich in soya phyto-oestrogens
over the last decade (Setchell & Cassidy, 1999), to date
limited research has been conducted to determine the bio-
availability of isoflavones from soya foods and define the
relative importance of factors such as age and gender on
levels attained in vivo. The metabolism of isoflavones in
animals and man is complex, and is a combination of
both mammalian and gut microbial processes (Setchell &
Cassidy, 1999, Rowland et al. 2003; Setchell, 2000).
After ingestion, isoflavones are hydrolysed by intestinal
glucosidases, which release the aglycones daidzein, gensi-
tein and glycitein. These may be absorbed or further
metabolised to many specific metabolites including equol
and p-ethyl phenol (Axelson et al. 1984; Bannwart et al.
1984; Kelly et al. 1993; Joannou et al. 1995). Because
there are currently no guidelines on optimal levels of iso-
flavones and there are limited data on their bioavailability
from foods (Xu et al. 1994; Setchell et al. 2001, 2003a,b),
dietary intakes in clinical studies examining the risks and
benefits of isoflavones for human health have to date
been empirically derived. The daily intake of around
50 mg isoflavones/d, which has predominantly been used
in clinical intervention studies, appears to be largely
based on our earlier observation that the daily consumption
of soya foods containing 45 mg isoflavones caused endo-
crine modulation of the menstrual cycle in healthy pre-
menopausal women (Cassidy et al. 1994, 1995). More
recently there has been a tendency to use relatively large
dietary intakes of soya isoflavones derived from foods or
supplements far exceeding typical consumption levels in
Asian countries, which range from 15–50 mg/d (Nagata
et al. 1998; Chen et al. 1999; Wakai et al. 1999). However,
the rationale for these higher intakes remains unclear and is
not based on the knowledge of isoflavones’ pharmaco-
kinetic behaviour. As with pharmacological compounds,
demonstrating the efficacy of soya and its isoflavones
requires knowledge of their bioavailability but to date
there is limited information on how this varies among sub-
jects and whether it is influenced by age or other factors.
Although it is well established that infants, in contrast to
adults, are unable to metabolise isoflavones (Setchell et al.
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1997), to date there are no data available examining the
effect of age on isoflavone metabolism and absorption in
later life. This is particularly important since much of the
current interest in relation to isoflavones relates to the
health of post-menopausal women, but to date many
studies investigating the biological effects of these
compounds have been carried out in premenopausal
women (Cassidy et al. 1994, 1995). Furthermore, the influ-
ence of gender is contentious with several studies
suggesting that urinary isoflavone kinetics are not related
to gender (Setchell et al. 1984; Kelly et al. 1993; Kirkman
et al. 1995; Lampe et al. 1998) while others are suggestive
of a gender difference in the absorption and metabolism of
these compounds (Lu & Anderson, 1998).
In Asian countries where soya is consumed as a staple it
remains to be determined if the chemical composition of
the soya food alters absorption and metabolism and thus
the potential biological efficacy of soya isoflavones.
Asian populations have traditionally consumed primarily
fermented soya protein products, and since these foods
contain a higher proportion of aglycone isoflavones, it
has been suggested that they may be more bioavailable
since these aglycone isoflavones do not require hydrolysis
in the intestine before absorption. There are preliminary
suggestions that urinary recoveries of daidzein and genis-
tein following the ingestion of fermented soya foods may
be greater (Cassidy et al. 1995; Hutchins et al. 1995).
However, this contrasts with recent data on the pure
compounds, which suggest no differences in the apparent
bioavailability of pure daidzein and gensitein tablets
when consumed as either aglycones or glycosides (Zubik
& Meydani, 2003). Although in their purified form, daid-
zein and genistein aglycones are more rapidly absorbed
into the systemic circulation (Izumi et al. 2000; Setchell
et al. 2001), other data suggest that the overall systemic
bioavailability of the pure aglycone compounds is lower
compared with their glycoside forms (daidzein and genis-
tein; Setchell et al. 2001). However, whether the same
effects are observed when subjects are fed different soya
foods containing isoflavones in the conjugated or unconju-
gated form remains to be investigated.
In human intervention trials investigating the biological
effects of these compounds in relation to human health,
urinary phyto-oestrogens are frequently used as a bio-
marker of their potential bioavailability from foods or
supplements rich in these compounds. This is in part
because urine is an easier biological sample to collect,
and because urine contains 100-fold higher concentrations
of isoflavones (Cassidy et al. 1994; Setchell et al. 2001,
2003a,b). Our recent data from pharmacokinetic studies
using stable isotopes of the pure isoflavone compounds,
daidzein and genistein, suggest that the collection of
random urine samples does not correlate with serum
measurements, but 24 h urine collections monitored for
completeness with an exogenous marker correlate well
with serum assessment of systemic bioavailability of
these compounds (Setchell et al. 2003b). Additionally,
quantitative assessment in urine provides information on
the extent of intestinal metabolism of isoflavones and
provides information on subject compliance within soya
intervention trials.
Knowledge of the factors that influence urinary isofla-
vone excretion will be key to optimising the intake of
soya foods in subgroups of the population. The aim of
the present study was to evaluate the effect of age,
gender, food matrix, and chemical composition on the urin-
ary excretion of the soya isoflavones, daidzein and genis-
tein, and the daidzein metabolite, equol.
Methods
Foods
In order to examine the effect of the food matrix on urinary
levels of isoflavones, a commercially available soya milk
(Sanitarium, NSW, Australia), and a source of textured
vegetable protein (TVP; Goodness Foods, Daventry, UK)
were purchased. The chemical composition of the soya
foods was compared using tempeh (Impulse Foods,
Rooksbridge, Somerset, UK) as a source of predominantly
unconjugated isoflavones over the 1·5-year period of the
study. Two batches of commercially available soya milk
and tempeh and one batch of TVP were used. The isofla-
vone content of each batch was analysed using the
method of Setchell et al. (1997) (see Table 1) and
the levels fed to the subjects were adjusted to ensure that
the total isoflavone levels fed remained constant through-
out the study periods.
The soya milk was administered as purchased and
provided a liquid soya-food matrix in which the isoflavones
were predominantly found as conjugates (Table 1). The TVP
(solid matrix) also contained isoflavones predominantly
in the conjugated form (Table 1) and was given to each sub-
ject as bread rolls, which had been prepared in advance and
Table 1. Isoflavone content of soyabean products as purchased (following analysis by the method of Setch-
ell et al. 1997)
Isoflavone content
(mg aglycone equivalents/g)
Percentage daidzein and
Food Total Daidzein Genistein genistein in aglycone form
Soya milk Batch 1 63·9 19·6 22·3 14·1
Batch 2 50·3 15·2 28·3 5·9
TVP Batch 1 476·0 163·1 312·8 8·2
Tempeh Batch 1 234·4 72·4 140·3 50·0
Batch 2 345·6 137·1 186·4 48·1
TVP, textured vegetable protein.
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stored at2208C until required. The tempeh (solid soya-food
matrix) contained a significant proportion of isoflavones in
the aglycone form (Table 1). It was prepared into burgers
and frozen at2208C until required. The variability between
the batches of both soya milk and tempeh was also tested but
no statistical differences were found in the recoveries
between the batches of foods.
Subjects
The subjects were recruited from the staff and student popu-
lation at the University of Surrey and surrounding area.
Twenty premenopausal women, seventeen post-menopausal
women and twenty men were recruited to participate in
the present studies. All individuals were healthy, reported
no use of medications, including antibiotics (previous
6 months) and were not regular consumers of soya foods.
The premenopausal women reported regular menstrual
cycles and were not currently using oral contraceptives or
hormone-releasing contraceptive devices. The post-meno-
pausal women reported no menstrual bleeding for at least
2 years. Healthy men between the ages of 18 and 55 years
were recruited. The ethics committee of the University of
Surrey approved the study protocol. Informed written
consent was obtained following a full explanation of the
study protocol to each subject.
Study design
Subjects were studied on three separate occasions and were
randomly assigned to receive a different soya food on three
occasions. Subjects were instructed and asked to adhere to
a soya-free diet for 1 month before and for the duration of
the study. Following an overnight fast they arrived at the
Clinical Investigation Unit at the University of Surrey
and received a 0·44 mg soya isoflavones/kg body weight
dose as soya milk, TVP rolls or tempeh burgers on three
separate occasions under supervision. Each dose was separ-
ated by a minimum of a 2-week washout period.
Each subject collected a baseline 24 h urine collection
before the ingestion of each soya food. All subjects contin-
ued to complete consecutive pooled 24 h urine collections
for the following 4 d. The volume of each 24 h pooled
urine collection was recorded and 30 ml homogeneous
samples were stored at 2808C for analysis. To check the
completeness of each collection, all subjects consumed
3 £ 80 mg p-aminobenzoic acid (Laboratory of Applied
Biology Ltd, London, UK) daily during the 5 d of urine
collections and the recovery of this marker was measured
(Bingham & Cummings, 1983).
Urinary isoflavones analysis
Urinary daidzein, genistein and equol concentrations were
determined by a modification of the GC–MS methods pre-
viously described by Setchell et al. (1984).
Following the addition of internal standards (500 ng each
of [13C]daidzein, [13C]genistein and [13(3)C]equol), the
urine (0·5 ml) was hydrolysed overnight at 378C in 0·1 ml
Helix pomatia extract (Sigma-Aldrich Chemical Co.,
Poole, UK). The samples were then acidified using 2
M-acetic acid (100ml) and the isoflavones extracted in
diethyl ether. The phenolic fraction was dried under a
stream of N2 at 658C. tert-Butyldimethylsilyl ether deriva-
tives were formed by the addition of acetonitrile (100ml)
and N-methyl-N-t-butyldimethylsilyltrifluoroacetamide in
1 % t-butyldimethylchlorosilane (100ml) and incubation
at 658C for 2 h.
The isoflavone tert-butyldimethylsilyl ether derivatives
were chromatographically separated and quantified using
selective ion monitoring GC–MS. Separation occurred on
a DB-1 column (15 m £ 0·25 mm internal diameter,
0·10 mm film thickness; J & W Scientific, Folsom, CA,
USA) with He as the carrier gas and a temperature pro-
gramme from 200 to 2808C with increments of 308C/min,
held for 6 min. The following ions were monitored for
daidzein, [13C]daidzein, genistein, [13C]genistein, equol,
and [13C]equol: mass:charge ratio (m/z) 425, m/z 426,
m/z 555, m/z 556, m/z 470 and m/z 473 respectively. The
quantification of isoflavone levels was determined by com-
paring the peak area in the specific ion channels, at the
retention time of the ether derivative corresponding to
the compound, compared with the 13C-labelled internal
standard.
A repeat analysis of a pooled sample of urine from sub-
jects consuming soya food was used as a quality control
during the analysis of each batch of samples. The mean
between-batch reproducibility (CV) for daidzein, genistein
and equol was 11·9, 9·3 and 12·8 % respectively and
within-batch reproducibility (CV) for daidzein, genistein
and equol was 4, 3 and 7 % respectively.
Statistical analyses
Data analysis was carried out using the Statistical Analysis
Systems statistical software package (SAS Institute, Cary,
NC, USA). All data are expressed as mean values with
their standard errors unless otherwise stated. A two-way
ANOVA model was fitted to the data to account for the
two fixed effects, being group (i.e. premenopausal
women, post-menopausal women or men) and food
(i.e. soya milk, TVP or tempeh). A fixed effect according
to the interaction between these two fixed effects (food £
group effect) was included if significant. A random effect
was also fitted to the model to account for intra-individual
variation. Tukey–Kramer methods were used for multiple
testing. Urinary recovery is expressed as aglycone equiva-
lents ingested.
Results
Subject characteristics and compliance
The age ranges of the premenopausal women, post-meno-
pausal women and men were 18–53, 48–69 and 18–55
years respectively. Doses of isoflavones were fed on a
mg/kg body-weight basis and the subjects’ body weights
ranged from 54 to 110 kg. BMI was not significantly differ-
ent between the groups and ranged from 16 to 34 kg/m2.
Compliance with the test diet was determined using the
exogenous marker, p-aminobenzoic acid (Bingham &
Cummings, 1983), and only those subjects who provided
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complete 24 h pooled urine collections across all three
soya-food periods were included in the final analysis; four-
teen premenopausal women, thirteen post-menopausal
women and fifteen men.
Urinary daidzein and genistein recovery
The mean daily urinary recoveries of daidzein and genis-
tein following challenges with the different soya foods
are shown in Fig. 1. With all three foods tested, the
majority of daidzein and genistein was recovered in urine
within the first 24 h following ingestion of the food. Low
levels of daidzein and genistein were measurable on day
2 but by days 3 and 4 urinary excretion of these com-
pounds was negligible and had returned to baseline levels
(see Fig. 1). The mean urinary excretions of total daidzein
and genistein on day 2 were 0·38 (SD 0·32), 0·37 (SD 0·36)
and 0·46 (SD 0·41) mg/d for milk, TVP and tempeh respect-
ively. Urinary daidzein recovery in days 1 and 2 was con-
sistently higher than that of urinary genistein over the three
foods studied.
The absolute recovery (mmol excreted) and dose recov-
ered (corrected for aglycone equivalents) of the parent
compounds following the ingestion of soya milk, TVP
and tempeh are given in Fig. 2. A significant food effect
(P.0·0001; ANOVA) was observed in absolute urinary
isoflavone recovery with greatest recovery in the order of
tempeh . milk . TVP (with a non-significant difference
between soya milk and tempeh). However, after correction
for the recovery of aglycone equivalents ingested, no real
food effect was observed, suggesting that differences in
the isoflavone composition of the soya foods contributed
to the proposed differences in recoveries between the
foods studied. No group differences, i.e. between men
and women, and between premenopausal and post-meno-
pausal women were observed in absolute recovery or
dose recovered.
Table 2 shows the cumulative daidzein and genistein
excretion in the pooled urine collections. The cumulative
excretion (percentage dose recovered) of daidzein did not
differ between the groups or foods consumed, and no
food £ group interaction was noted. In contrast a signifi-
cant food effect (P,0·0001; ANOVA) and a food £ group
interaction (P¼0·01; ANOVA) was noted in the model for
the cumulative urinary excretion of genistein (percentage
dose recovered). In both groups of women no differences
were observed in urinary genistein recovery between the
TVP and tempeh diet periods but urinary recovery was sig-
nificantly higher in both groups of women (P,0·001 and
P,0·05, premenopausal and post-menopausal women
respectively; ANOVA with Tukey–Kramer) when they
were fed soya milk compared with the TVP study period.
In premenopausal women, urinary genistein recovery was
also significantly higher (P,0·001; ANOVA with
Tukey–Kramer) following milk ingestion compared with
tempeh. A similar trend was observed for the post-meno-
pausal women but it was not statistically significant. No
difference in the recoveries of urinary genistein between
soya foods was observed in the men. Between groups no
significant difference in the recovery of genistein was
observed following the ingestion of TVP and tempeh.
However, following soya-milk ingestion, premenopausal
Fig. 1. Urinary daidzein (A) and genistein (B) excretion profiles at
baseline (BL) and following challenge with 0·44 mg isoflavones/kg
body weight of soya milk (A), textured vegetable protein (B) and
tempeh (B) in men (n 15), post-menopausal women (n 13) and pre-
menopausal women (n 14). Mean values are shown, with standard
errors represented by vertical bars.
Fig. 2. Cumulative recovery of total daidzein and genistein over
four consecutive days (pooled 24 h urine collections) following the
ingestion of 0·44 mg isoflavones/kg body weight of soya milk, tex-
tured vegetable protein (TVP) and tempeh, expressed as (A) absol-
ute recovery (mmol excreted) and (B) urinary recovery of ingested
doses corrected for aglycone equivalents. Mean values are shown,
with standard errors represented by vertical bars.
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women had a higher (P,0·052; ANOVA with Tukey–
Kramer) recovery of genistein compared with the men.
Urinary equol excretion
The urinary equol excretion profiles are shown in Fig. 3.
As expected, equol appeared in the urine during days 1
and 2 following the ingestion of soya foods, slowly return-
ing to baseline levels during day 4. Six premenopausal
women, four post-menopausal women and one male con-
sistently excreted equol following the ingestion of the
three soya foods. One premenopausal woman excreted
equol following tempeh ingestion and three men each
excreted equol only following the ingestion of one soya
food (each a different soya food). The cumulative urinary
recovery of equol was significantly higher following
tempeh ingestion compared with the other two soya
foods (P,0·01; ANOVA).
Discussion
There is currently little information on factors that influence
the bioavailability of soya isoflavones from food.
Previous bioavailability studies have tended to focus on
the urinary excretion of the isoflavones and their metabolites
following the ingestion of purified compounds or a single
food source or in a single population group (Cassidy et al.
1994; King & Bursill, 1998; Izumi et al. 2000; Setchell
et al. 2001, 2003a,b; Zubik & Meydani, 2003). In the
present study, the influence of age, gender, food matrix
and chemical composition on the levels of daidzein and
genistein and the daidzein metabolite, equol, in urine were
determined.
In agreement with previous studies, wide inter-individ-
ual variability in the urinary recovery of daidzein and
genistein was observed (Karr et al. 1997; Rowland et al.
1999). In the present study (n 42), the recovery of total
daidzein and genistein was 31·1 and 13·0 % respectively
of total isoflavones ingested, with daidzein and genistein
recoveries ranging from 8 to 100 % and 4 to 94 %
respectively.
The use of urinary isoflavone excretion is widespread in
clinical trials as a marker of compliance with the dietary
intervention and as an assessment of the bioavailability
of these compounds from soya foods and supplements. It
is well established that following soya-food consumption,
urinary daidzein concentrations are consistently higher
than urinary genistein levels (King & Bursill, 1998; Wata-
nabe et al. 1998; Zhang et al. 1999; Setchell et al. 2003b).
This suggests that the fraction of ingested daidzein
absorbed is greater than that of genistein. Conversely, the
daidzein:genistein ratio is reversed in blood when equal
amounts of the two compounds are ingested resulting in
greater bioavailability of genistein than daidzein in the
systemic circulation (Setchell et al. 2003b). In a recent
study using stable isotopes of daidzein and genistein we
demonstrated a weak correlation between serum and
urinary isoflavone concentrations (Setchell et al. 2003b).
However, total 24 h urinary isoflavone output (mmol)
(monitored for completeness using an exogenous marker)
correlated highly with serum concentrations demonstrating
the necessity for complete 24 h urine collections when
investigating the physiological behaviour of these com-
pounds and providing the rationale for this approach in
the present study.
The excretion profiles of daidzein and genistein over the
96 h following the ingestion of the soya foods are similar to
that which we previously observed (Setchell et al.
2003a,b), with the majority appearing in the urine within
the first 24 h following the ingestion of the soya food.
Table 2. Cumulative urinary daidzein and genistein excretion over four pooled 24 h urine collections in subjects challenged with 0·44 mg isofla-
vones/kg body weight as soya milk, textured vegetable protein (TVP) and tempeh
(Mean values with their standard errors)
Daidzein* Genistein*
Premenopausal
women (n 14)
Post-menopausal
women (n 13) Men (n 15)
Premenopausal
women (n 14)
Post-menopausal
women (n 13) Men (n 15)
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
Soya milk 51·6 5·0 60·6 8·7 59·2 4·8 47·1†‡ 5·7 29·9§ 5·4 28·7 5·2
TVP 49·9 4·1 45·7 6·1 53·7 4·9 18·7 2·0 14·1 1·8 21·7 3·8
Tempeh 53·9 4·0 63·6 9·6 48·2 4·7 22·8 2·0 18·0 3·0 22·2 4·2
* Data were analysed by a two-way ANOVA with group and food being the main effects. A significant food effect (P,0·0001) and a food £ group interaction
(P¼0·01) were noted in genistein recovery.
† For genistein recovery, mean value was marginally significantly different from that for men (P¼0·052) (ANOVA with Tukey–Kramer test).
‡ For genistein recovery, mean value was significantly different from those for TVP and tempeh (P¼0·001) (ANOVA with Tukey–Kramer test).
§ For genistein recovery, mean value was significantly different from that for TVP (P,0·05) (ANOVA with Tukey–Kramer test).
Fig. 3. Urinary equol excretion over the study period following the
ingestion of a single dose of 0·44 mg isoflavones/kg body weight as
soya milk (A), textured vegetable protein (B) and tempeh (B).
Mean values are shown, with standard errors represented by verti-
cal bars. Two male subjects (13 %) produced equol, while ten to
eleven women produced equol (37–41 %).
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This rapid appearance of these compounds in urine can be
explained by the short serum half-life and fast serum clear-
ance rates of both daidzein and genistein. Other investi-
gations of the urinary excretion patterns of these
compounds following acute ingestion have also reported
low excretion rates 24 h post ingestion (King & Bursill,
1998; Watanabe et al. 1998; Setchell et al. 2003b).
The present study aimed to evaluate the potential impact
that age, gender, food matrix and chemical composition
may have on urinary isoflavone excretion following the
consumption of a single portion of three soya foods in
the same group of subjects. Absolute urinary recovery of
daidzein and genistein was significantly greater following
the ingestion of tempeh than that of the other two foods
and there was a trend towards higher excretion following
TVP than tempeh. However, to validly compare the three
foods and groups it was essential that urinary excretion
was expressed as percentage dose ingested following cor-
rection for aglycone equivalents, as although a fixed dose
(per kg body weight) was given to each individual, the
foods differed in composition of isoflavones. After correct-
ing for aglycone levels in the foods, there was no differ-
ence in total urinary isoflavone excretion. Daidzein
recovery remained similar across the groups studied for
the three soya foods. However, genistein urinary output
was altered by the test food studied and other factors.
The urinary recovery of genistein appeared to be influ-
enced by gender and food matrix. In the men studied,
there was no difference in the recovery of genistein
across the three foods whereas urinary genistein recovery
was different in the women depending on the soya food
fed. Lu & Anderson (1998) previously reported a gender
effect, with data suggesting a decrease over time in daid-
zein and genistein excretion following chronic ingestion
(1 month) of soya milk in women but no changes in the
same study in male subjects. However, other studies have
not observed any gender effects on urinary isoflavone
recovery following the consumption of soya over similar
study periods (Kelly et al. 1993; Lampe et al. 1998).
Kelly et al. (1993) reported no differences in urinary isofla-
vone excretion in their male and female subjects following
the ingestion of 40 g soya flour for 2 d. Lampe et al. (1998)
reported higher carbohydrate and fibre intake among
female equol excreters compared with female non-equol
excreters in the females, but not in their male subjects.
Gender differences in plasma isoflavone pharmacokinetics
have also been reported. Lu & Anderson (1998) reported
longer half-lives for daidzein and genistein in females
compared with males, while in the rat, Slikker et al.
(2001) reported that the area under the curve for genistein
was greater in females compared with males. In the present
study there was a trend towards premenopausal women
excreting more genistein than males, suggestive of a poten-
tial gender effect. The present study appears to show a
greater sensitivity of females to the type of food ingested
to acute isoflavone dosing, although the effect of chronic
feeding remains to be evaluated. However, we have
previously demonstrated no significant difference in the
physiological handling of 13C-labelled daidzein and genis-
tein following the previous ingestion of soya milk com-
pared with a single oral dose of these compounds
(Setchell et al. 2003b). The mechanism behind the
gender difference is unclear. However, dietary factors
such as fibre and carbohydrate have been previously
associated with differences in the metabolism of daidzein
to equol (Axelson et al. 1984; Cassidy, 1991; Lampe
et al. 1998; Rowland et al. 1999; Setchell & Cassidy,
1999). In the present study, subjects were studied on
three separate occasions, where soya intake was randomly
assigned. Although no dietary intake data were collected
during the study periods, subjects were requested to con-
sume their habitual diet and avoid soya-containing foods.
Therefore the potential effect of other dietary components
(for example, carbohydrate or dietary fibre) in explaining
the observed differences cannot be addressed in the present
study.
The data from females suggest that isoflavone excretion
may be altered depending on the food matrix consumed. In
both groups of women, the urinary genistein recovery was
greater following the ingestion of soya milk compared with
TVP and tempeh, although the difference in post-menopau-
sal urinary genistein excretion between milk and tempeh
was not significant. The available data suggest that purified
daidzein and genistein are absorbed faster than isoflavones
from soya foods (Izumi et al. 2000) but the present study is
the first study to compare different food matrices.
Daidzein and genistein excretion accounts for approxi-
mately one-third of the total isoflavones ingested. In the
present study, glycitein was not accounted for but the gly-
citein content of soyabean-derived products is small. The
metabolism of daidzein and genistein in the intestine may
account for some of the rest of the urinary isoflavones
levels and various other metabolites have been identified
in biological fluids (Axelson et al. 1984; Kelly et al.
1993; Joannou et al. 1995; Coldham et al. 1999). In the
present study we focused on the metabolite of daidzein,
equol, as a marker of intestinal metabolism. Equol has
been the focus of much interest because it is more oestro-
genic and a more potent antioxidant than daidzein (Shutt &
Cox, 1972; Arora et al. 1998, Mitchell et al. 1998). This
suggests that this isoflavone metabolite may hold the key
to understanding the mechanism of action and effective-
ness of soya in clinical studies examining the potential
health benefits of soya isoflavones. It is well established
that only 30 % of any given population group studied can
produce equol (Cassidy et al. 1994, 1995; Lampe et al.
1998; Rowland et al. 1999). An inability to produce
equol may be related to an absence of appropriate enzymes
in the intestinal microflora or to an absence of bacterial
species capable of producing equol (Axelson et al. 1984;
Setchell et al. 1984). Its formation is exclusively related
to intestinal microflora as germ-free rats do not excrete
equol and the absence of equol from infant blood samples
following soya infant-formula ingestion add weight to the
need for an active microflora for its formation
(Setchell et al. 1997). Our studies in healthy adults using
[13C]daidzein and [13C]genistein show conclusively that
equol is formed from daidzein and not genistein (Setchell
et al. 2003b). The question of whether we can enhance
the intestinal conversion of daidzein to equol is one of
great interest (Axelson et al. 1984; Setchell et al. 2002)
and dietary carbohydrate has been indicated as a factor
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that may determine equol production (Axelson et al. 1984;
Cassidy, 1991; Lampe et al. 1998; Rowland et al. 1999;
Setchell & Cassidy, 1999). In the present study the urinary
recovery of equol was higher following the ingestion of
tempeh compared with the two other soya foods suggesting
that a combination of a fermented and solid food matrix
may enhance the production of equol. It is possible that a
solid food matrix protects daidzein from degradation
until it reaches the large intestine where it can be metab-
olised to equol by the microflora.
There was large variability in the incidence of equol pro-
duction among the study population. Although the present
study was too small to conduct valid statistical analysis on
equol production, a higher proportion of post-menopausal
women were consistently equol producers compared with
the premenopausal women and men. The present data
suggest that gender and age may be important determinants
of intestinal isoflavone metabolism but larger studies are
required to confirm these observations.
These data address the question of whether gender, age,
food matrix or chemical composition influence urinary iso-
flavone excretion. In the present study population, urinary
genistein excretion varied depending on the soya food con-
sumed. Although the men studied showed no change in
urinary isoflavones excretion between the soya foods, in
women, a food-matrix effect was observed with higher
levels of urinary genistein measured following soya-milk
consumption. The isoflavone precursor, daidzein, unlike
genistein, did not appear to be altered by age, gender or
food matrix yet the urinary excretion of its intestinal
metabolite, equol, was higher in women following the
consumption of tempeh, suggesting a matrix and chemi-
cal-composition effect. Further studies are required to
determine the relative importance of these factors in
elderly populations, as to date much of the interest in
soya isoflavones relates to post-menopausal health issues.
Such data will help in defining optimal levels and delivery
forms of these compounds for potential health benefits.
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